Blog Archives

Plaquenil/hydroxychloroquine may have more extraglandular benefits for Sjogren’s Syndrome patients

Hydroxychloroquine (generic Plaquenil) is often prescribed off-label by doctors for Sjogren’s Syndrome patients despite the fact that it has never been approved by governing agencies like the FDA. I myself have taken hydroxychloroquine for several years. Studies have generally found that hydroxychloroquine

Posted in Research, Treatment, Uncategorized Tagged with: ,

Abatacept open-label study for Sjogren’s Syndrome concludes with promising results.

Back in January, I wrote a post titled Hope for 2016 – 5 upcoming treatments for Sjogren’s Syndrome, I mentioned an active clinical trial using Orencia/Abatacept to treat Sjogren’s Syndrome. That trial is still ongoing, but a smaller Japanese trial for

Posted in Uncategorized

Virus-Like Elements in the Human Genome Linked to the Development of Sjogren’s Syndrome

I’ve had this one on my blog backlog for a month now, but I wanted to get it out there. While my #1 interest is in SS treatments, research that seeks to understand the underlying mechanisms of autoimmune diseases are

Posted in Research, Uncategorized Tagged with:
WordPress Appliance - Powered by TurnKey Linux